Robert Stuver - Concepedia

Author

Robert Stuver

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Epeldegui, M, R. Stuver, Robert N Stuver, Robert N. Stuver, Robert Stuver, Robert Stuver,, Stuver, Robert

124

Publications

621

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center City of Hope Mayo Clinic Harvard University

About

Robert Stuver is an author at Memorial Sloan Kettering Cancer Center specializing in cancer research, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	83
2	Immunology	3	3	83
3	Pathology	2	2	64
4	Health Sciences	1	1	19
5	Cellular Therapies	1	1	19

Robert Stuver

Publications

282

Citations

H-Index

Page 1

	Year	Citations
Mycosis Fungoides and Sézary Syndrome Robert Stuver, Alison J. Moskowitz, Sarah Noor,	2023	173
Single agents vs combination chemotherapy in relapsed and refractory peripheral T‐cell lymphoma: Results from the comprehensive oncology measures for peripheral T‐cell lymphoma treatment (COMPLETE) registry Robert Stuver, Niloufer Khan, Marc Schwartz, American Journal of Hematology Lymphoid NeoplasiaOncologyEligibility CriteriaComprehensive Oncology MeasuresImmunology	2019	40
<i>TP53</i>mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy W. Thomas Johnson, Nivetha Ganesan, Zachary D. Epstein‐Peterson, Blood Advances ImmunologyPathologyTumor BiologyHematological MalignancyOncology	2023	24
Final results of a phase <scp>II</scp> study of <scp>CHOEP</scp> plus lenalidomide as initial therapy for patients with stage <scp>II–IV</scp> peripheral T‐cell lymphoma Robert Stuver, Steven M. Horwitz, Ranjana H. Advani, British Journal of Haematology Cell TherapyImmunodeficienciesImmunologyImmunotherapyHematological Malignancy	2023	19
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma Pallawi Torka, Tatyana Feldman, Kerry J. Savage, Journal of Clinical Oncology	2024	14
PD-1 Blockade before Autologous Stem Cell Transplantation Improves Outcomes in Relapsed/Refractory Classic Hodgkin Lymphoma: Results from a Multicenter Cohort Sanjal H. Desai, Reid W. Merryman, Harsh Shah, Blood	2023	12

Page 1